Unveiling the Therapeutic Potential of hUCMSC-Derived EVs in Intervertebral Disc Degeneration through MALAT1/miR-138-5p/SLC7A11 Coexpression Regulation
Source abstract
Abstract
Intervertebral disc degeneration (IVDD) is a prevalent chronic condition causing spinal pain and functional impairment. This study investigates the role of extracellular vesicles (EVs) derived from human umbilical cord mesenchymal stem cells (hUCMSCs) in regulating IVDD. Using RNA-seq, we analyzed differential expressions of lncRNA and miRNA in nucleus pulposus tissues from various mouse groups. We identified key regulatory molecules, MALAT1 and miRNA-138-5p, which contribute to IVDD. Further experiments demonstrated that MALAT1 can up-regulate SLC7A11 expression by competitively binding to miR-138-5p, forming a MALAT1/miR-138-5p/SLC7A11 coexpression regulatory network. This study elucidates the molecular mechanism by which hUCMSC-derived EVs regulate IVDD and could help develop novel therapeutic strategies for treating this condition. Our findings demonstrate that hUCMSCs-EVs inhibit ferroptosis in nucleus pulposus cells, thereby improving IVDD. These results highlight the therapeutic potential of hUCMSCs-EVs in ameliorating the development of IVDD, offering significant scientific and clinical implications for new treatments.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Circular RNAs in diseases · Cancer-related molecular mechanisms research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Spine Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an 710054, Shaanxi, China
Shaanxi Key Laboratory of Spine Bionic Treatment, Xi’an 710054, Shaanxi, China
Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Department of Orthopedics, the First People’s Hospital of Tianshui City, Tianshui 741000, Gansu Province, China
Funding
Key Programme
References (68)
Show source-provided references
1. 10.1016/j.arr.2022.10173310.1016/j.arr.2022.101733 ↗
2. 10.1038/s41467-022-28387-510.1038/s41467-022-28387-5 ↗
3. 10.1016/j.jconrel.2020.08.04110.1016/j.jconrel.2020.08.041 ↗
4. 10.1007/s00586-021-07055-010.1007/s00586-021-07055-0 ↗
5. Saravi, B.; Lang, G.; Grad, S.; Alini, M.; Gantenbein, B.A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease J. Visualized Exp. 2021, 16810.3791/62100-v.10.3791/62100-v ↗
6. 10.1177/230949902096056010.1177/2309499020960560 ↗
7. 10.1186/s13287-023-03345-010.1186/s13287-023-03345-0 ↗
8. 10.4103/bc.bc_15_2110.4103/bc.bc_15_21 ↗
9. 10.1016/j.addr.2021.11396110.1016/j.addr.2021.113961 ↗
10. 10.7150/thno.7430510.7150/thno.74305 ↗
11. 10.1186/s13045-021-01141-y10.1186/s13045-021-01141-y ↗
12. 10.1038/s41580-022-00460-310.1038/s41580-022-00460-3 ↗
13. 10.1016/j.addr.2020.04.00410.1016/j.addr.2020.04.004 ↗
14. 10.1080/10717544.2020.174875810.1080/10717544.2020.1748758 ↗
15. 10.1002/cac2.1227510.1002/cac2.12275 ↗
16. 10.1016/j.annonc.2021.01.07410.1016/j.annonc.2021.01.074 ↗
17. 10.1016/j.cell.2022.04.01610.1016/j.cell.2022.04.016 ↗
18. 10.1016/j.freeradbiomed.2022.08.01810.1016/j.freeradbiomed.2022.08.018 ↗
19. 10.1002/jbmr.169210.1002/jbmr.1692 ↗
20. 10.3390/ijms1701013010.3390/ijms17010130 ↗
21. 10.3389/fcell.2023.121984010.3389/fcell.2023.1219840 ↗
22. 10.3389/fendo.2022.104206010.3389/fendo.2022.1042060 ↗
23. 10.1007/s00018-023-05067-110.1007/s00018-023-05067-1 ↗
24. 10.1016/j.redox.2023.10270710.1016/j.redox.2023.102707 ↗
25. An C. · Am. J. Clin. Exp. Urol. · 2022 · 10 · 170
26. 10.1155/2021/839016510.1155/2021/8390165 ↗
27. 10.1007/s13238-020-00789-510.1007/s13238-020-00789-5 ↗
28. 10.1186/s11658-020-00205-010.1186/s11658-020-00205-0 ↗
29. 10.1038/s41586-022-04754-610.1038/s41586-022-04754-6 ↗
30. 10.7150/thno.3923810.7150/thno.39238 ↗
31. 10.1038/s41467-018-07360-110.1038/s41467-018-07360-1 ↗
32. 10.1111/jcmm.1578410.1111/jcmm.15784 ↗
33. 10.3892/ijmm.2018.397210.3892/ijmm.2018.3972 ↗
34. 10.1038/s12276-018-0125-y10.1038/s12276-018-0125-y ↗
35. 10.1093/nar/gkt124810.1093/nar/gkt1248 ↗
36. 10.1038/mt.2009.14610.1038/mt.2009.146 ↗
37. 10.1002/jcp.3003910.1002/jcp.30039 ↗
38. 10.1007/s10565-020-09530-810.1007/s10565-020-09530-8 ↗
39. 10.1002/0471143030.cb0322s3010.1002/0471143030.cb0322s30 ↗
40. 10.1371/journal.pone.004206410.1371/journal.pone.0042064 ↗
41. 10.1111/jcmm.1331610.1111/jcmm.13316 ↗
42. 10.22203/eCM.v041a0710.22203/eCM.v041a07 ↗
43. 10.1016/j.mtbio.2022.10051210.1016/j.mtbio.2022.100512 ↗
44. 10.1002/ctm2.149410.1002/ctm2.1494 ↗
45. 10.1016/j.jphotobiol.2016.05.02710.1016/j.jphotobiol.2016.05.027 ↗
46. 10.18632/aging.10240510.18632/aging.102405 ↗
47. 10.1155/2021/667049710.1155/2021/6670497 ↗
48. 10.1016/j.biopha.2019.10936510.1016/j.biopha.2019.109365 ↗
49. 10.1016/j.freeradbiomed.2019.07.02610.1016/j.freeradbiomed.2019.07.026 ↗
50. 10.7150/thno.3363810.7150/thno.33638 ↗
51. 10.1186/s13287-017-0563-910.1186/s13287-017-0563-9 ↗
52. 10.1016/j.canlet.2020.02.01510.1016/j.canlet.2020.02.015 ↗
53. 10.18632/aging.20252010.18632/aging.202520 ↗
54. Zhang H. · Int. J. Clin. Exp. Pathol. · 2017 · 10 · 10611
55. 10.1016/j.yexcr.2016.05.01110.1016/j.yexcr.2016.05.011 ↗
56. 10.1038/nature1434410.1038/nature14344 ↗
57. 10.1186/s12951-021-00991-510.1186/s12951-021-00991-5 ↗
58. 10.1038/s41467-022-28990-610.1038/s41467-022-28990-6 ↗
59. 10.3389/fendo.2023.110087410.3389/fendo.2023.1100874 ↗
60. 10.1186/s12951-021-01236-110.1186/s12951-021-01236-1 ↗
61. 10.1186/s13287-022-03005-910.1186/s13287-022-03005-9 ↗
62. 10.1186/s13287-021-02529-w10.1186/s13287-021-02529-w ↗
63. 10.1016/j.lfs.2019.11673310.1016/j.lfs.2019.116733 ↗
64. 10.3727/096368915X68684110.3727/096368915X686841 ↗
65. 10.1007/s12015-023-10521-510.1007/s12015-023-10521-5 ↗
66. 10.1080/02648725.2023.217550110.1080/02648725.2023.2175501 ↗
67. 10.1016/j.bioactmat.2023.05.00510.1016/j.bioactmat.2023.05.005 ↗
68. 10.3389/fbioe.2022.93390110.3389/fbioe.2022.933901 ↗